COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The INFECIR-2 Albumin Prevention Study (INFECIR2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02034279
Recruitment Status : Terminated (Low recruitment rate and expiration of the study drug)
First Posted : January 13, 2014
Last Update Posted : May 18, 2017
Information provided by (Responsible Party):
EASL - CLIF Consortium

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : February 10, 2017
Publications automatically indexed to this study by Identifier (NCT Number):